Bristol Myers Squibb taps AI Proteins in drug discovery collaboration worth up to $400M

Bristol Myers Squibb taps AI Proteins in drug discovery collaboration worth up to $400M

Source: 
Fierce Biotech
snippet: 

Bristol Myers Squibb has enlisted three-year-old Massachusetts biotech AI Proteins to use its artificial intelligence-driven platform to discover and develop therapeutic miniproteins for two undisclosed targets.